edoxaban

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Anticoagulation in Patients With Venous Thromboembolism and Cancer

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

Effects of Edoxaban on Platelet Aggregation

Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria

The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)

Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

Resolution of Thrombi in Left Atrial Appendage With Edoxaban

EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients

Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer